| AIM2 | absent in melanoma 2 |
| ALT | alanine aminotransferase |
| Ang-2 | angiopoietin-2 |
| AST | aspartate aminotransferase |
| AUC | area under the curve |
| BMI | Body Mass Index |
| BMP-9 | bone morphogenetic protein-9 |
| CAP | controlled attenuation parameter |
| CASP1 | caspase-1 |
| CD105 | endoglin |
| EGF | epidermal growth factor, |
| ET1 | endothelin-1 |
| FGF-1 | fibroblast growth factor-1 |
| FGF-2 | fibroblast growth factor-2 |
| FST | follistatin |
| G-CSF | granulocyte colony-stimulating factor |
| GGT | gamma-glutamyl transferase |
| HB-EGF | heparin-binding EGF-like growth factor |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HDL | High-density lipoprotein |
| HGF | hepatocyte growth factor, |
| IL-2 | interleukin-2 |
| IL-8 | interleukin-8 |
| INR | International Normalized Ratio |
| LDL | Low-density lipoprotein |
| LEP | leptin |
| LSM | Liver stiffness measurement |
| NAFLD | Nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| NRLP3 | Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing 3 |
| P2X4R | P2X purinoceptor 4 |
| P2X7R | P2X purinoceptor 7 |
| PLGF | placental growth factor |
| ROC | receiver operating characteristics |
| T/R | target-reference ratio |
| VEGF-A | vascular endothelial growth factor-A |
| VEGF-C | vascular endothelial growth factor-C |
| VEGF-D | vascular endothelial growth factor-D |